Drug Patents owned by Hisamitsu
1. List of Secuado drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10583121 | HISAMITSU | Patch |
Jul, 2033
(10 years from now) | |
| US10814002 | HISAMITSU | Patch and method for producing the same |
Jul, 2033
(10 years from now) | |
| US9687474 | HISAMITSU | Patch |
Jul, 2033
(10 years from now) | |
| US10022445 | HISAMITSU | Patch |
Jul, 2033
(10 years from now) | |
| US11123305 | HISAMITSU | Patch |
Jul, 2033
(10 years from now) | |
Do you want to check out SECUADO patents from before 2022?
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Product (NP) | Oct 11, 2022 |
Drugs and Companies using ASENAPINE ingredient
Market Authorisation Date: 11 October, 2019
Treatment: Method of treating adults with schizophrenia comprising administering asenapine via a transdermal patch
Dosage: SYSTEM;TRANSDERMAL
More Information on Dosage
SECUADO family patents
15
United States
10
Japan
3
Korea, Republic of
3
China
3
Spain
3
Taiwan
3
European Union
2
Poland
2
Portugal
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic